The Global Hypoglycemic Drugs Market Growth Accelerated By Emerging Demand In Developing Countries

Hypoglycemic Drugs Market
 

 Hypoglycemic drugs help reduce blood sugar levels for diabetes treatment and management. Various products are available in oral and injectable forms for type-1 and type-2 diabetes patients to regulate blood sugar throughout the day. The demand for these drugs is rising significantly owing to the growing prevalence of diabetes globally.

The global Hypoglycemic Drugs Market is estimated to be valued at US$ 830.27 Mn in 2024 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The demand for hypoglycemic drugs is witnessing high growth in developing countries owing to improving access to healthcare facilities and diagnosis of diabetes. As per the International Diabetes Foundation, around 98 million people in India suffered from diabetes in 2019. China has the world's largest diabetic population of around 116 million. Growing awareness initiatives by healthcare organizations and governments are encouraging more people to get screened and opt for timely treatment in these countries. As diabetes cases continue to rise in emerging economies at a higher rate than developed nations, the market for hypoglycemic drugs is expected to gain strong momentum over the forecast period primarily driven by expanding sales volumes in Asia Pacific and other developing regions globally.


Segment Analysis
The global hypoglycemic drugs market is dominated by oral antidiabetic drugs sub segment, which captures around 65% of the total market share. This is because oral drugs are preferred first line treatment for diabetes management owing to their ease of administration and cost effectiveness as compared to insulin drugs. Within oral antidiabetic drugs, sulfonylureas has been the largest and dominating category historically, however DPP-4 inhibitors sub segment is witnessing higher growth trajectory due to better safety and tolerability profile.

Key Takeaways

The global Hypoglycemic Drugs Market analysis is estimated to be valued at US$ 830.27 Mn in 2024 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024 to 2031.


Regional analysis related content comprises
The North American region currently dominates the hypoglycemic drugs market owing to growing incidence of diabetes, strong reimbursement structure, higher healthcare spending and presence of key market players in the region. However, Asia Pacific region is projected to witness highest growth during the forecast period due to rising geriatric population, growing obesity, sedentary lifestyle in developing countries like India and China which is propelling the diabetes patient pool.

Key players related content comprises
Key players operating in the hypoglycemic drugs market are Pfizer Inc., Novartis AG, Merck & Co., Inc., Celgene Corporation, AstraZeneca PLC, Astellas Pharma Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, and Johnson & Johnson (Janssen Global Services, LLC).

Get more insights on this topic: https://www.newswirestats.com/hypoglycemic-drugs-market-industry-insights-trends-hypoglycemic-drugs-market/

Comments

Post a Comment

Popular posts from this blog

The Global Naloxone Market Is Set To Experience Exponential Growth Owing To Rising Opioid Overdoses

Image
   naloxone market The naloxone market has experienced significant growth in recent years owing to increasing cases of opioid overdoses across the globe. Naloxone is an opioid antagonist medication used to reverse the effects of opioid overdoses including life-threatening depression of central nervous system and respiratory functions. The global naloxone market is estimated to be valued at US$ 1,422.26 million in 2024 and is expected to exhibit a CAGR of 4.7% over the forecast period of 2024-2030. Naloxone is administered as an injection into a muscle or vein or as a nasal spray. It is effective against both natural and synthetic opioids such as morphine, heroin, oxycodone, fentanyl, and methadone. Rising abuse and misuse of prescription opioids and increasing societal acceptability of opioids for pain management have been identified as major causes of opioid epidemics in many countries. Moreover, governmental support through policy and funding initiatives for wider public...
Read more

Feminine Hygiene Products Market Growth Accelerated By Rising Awareness About Women Hygiene

Image
Feminine Hygiene Products Market    Feminine hygiene products provide effective solutions for maintaining women's intimate hygiene and offer convenience during menstrual cycles. Sanitary pads, tampons, panty liners, and menstrual cups are commonly used feminine hygiene products that efficiently absorb menstrual blood flow. The growing awareness about women's hygiene and health and availability of innovative product varieties catering to different needs have accelerated the demand for these products. Factors such as changing lifestyles and rising incomes have further contributed to the increased spending on intimate healthcare needs of women. The global Feminine Hygiene Products Market is estimated to be valued at US$ 41.71 Bn in 2024 and is expected to exhibit a CAGR of 23.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends driving the growth in the feminine hygiene products...
Read more

The Global Antimicrobial Plastics Market Growth Accelerated By Increased Safety Measures

Image
Antimicrobial Plastics Market   Antimicrobial plastics are a range of plastics that are incorporated with antimicrobial additives which make them capable of destroying microbes and bacteria. They help reduce the growth and spread of microbes and are highly effective against pathogens. These plastics find wide usage in healthcare, packaging, food and beverage industries due to their ability to inhibit microbial growth. The global Antimicrobial Plastics Market is estimated to be valued at US$ 37.35 Bn in 2024 and is expected to exhibit a CAGR of 9.8% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increased usage of antimicrobial plastics can be attributed to the rising safety measures across industries. With growing awareness regarding hygiene and safety, antimicrobial plastics are being increasingly used in applications such as food packaging, healthcare and medical devices. Their effecti...
Read more